Sanofi Stock Today
| SNYNF Stock | USD 105.85 0.50 0.47% |
Performance1 of 100
| Odds Of DistressLess than 9
|
Sanofi is trading at 105.85 as of the 29th of January 2025. This is a 0.47 percent increase since the beginning of the trading day. The stock's lowest day price was 105.85. Sanofi has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. The performance scores are derived for the period starting the 1st of October 2024 and ending today, the 29th of January 2025. Click here to learn more.
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. Sanofi was founded in 1973 and is headquartered in Paris, France. Sanofi-Aventis operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. The company has 1.25 B outstanding shares. More on Sanofi
Moving together with Sanofi Pink Sheet
| 0.72 | RHHBF | Roche Holding AG Earnings Call Tomorrow | PairCorr |
| 0.87 | RHHBY | Roche Holding Earnings Call Tomorrow | PairCorr |
| 0.89 | RHHVF | Roche Holding AG Earnings Call Tomorrow | PairCorr |
Moving against Sanofi Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Sanofi Pink Sheet Highlights
| President | JeanBaptiste Chatillon |
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
Sanofi [SNYNF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Mega-Cap' category with a current market capitalization of 120.25 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sanofi's market, we take the total number of its shares issued and multiply it by Sanofi's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sanofi classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 1.25 B outstanding shares.
Sanofi has accumulated about 6.9 B in cash with 10.52 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.51.
Check Sanofi Probability Of Bankruptcy
Ownership AllocationSanofi shows a total of 1.25 Billion outstanding shares. 30% of Sanofi outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sanofi Ownership Details
Sanofi Risk Profiles
| Mean Deviation | 1.44 | |||
| Semi Deviation | 2.11 | |||
| Standard Deviation | 2.55 | |||
| Variance | 6.49 |
Sanofi Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sanofi without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Sanofi Corporate Management
| Roy Papatheodorou | Gen VP | Profile | |
| Josephine Fubara | Chief Care | Profile | |
| Paul Hudson | CEO Director | Profile | |
| Pierre Chancel | Sr Marketing | Profile | |
| Bruno Mnard | Chief officer | Profile | |
| Laurent Gilhodes | Principal Accounting | Profile |
Other Information on Investing in Sanofi Pink Sheet
Sanofi financial ratios help investors to determine whether Sanofi Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sanofi with respect to the benefits of owning Sanofi security.